MORGAN STANLEY PLC/CALL/PFIZER INC/56.5/0.1/17.01.25 Stock

Warrant

DE000MB32GY8

Real-time Bid/Ask 03:59:11 2024-06-27 EDT
0.013 EUR / 0.04 EUR +92.86% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/56.5/0.1/17.01.25
Current month+40.00%
1 month+40.00%
Date Price Change
24-06-27 0.013 -7.14%
24-06-26 0.014 +16.67%
24-06-25 0.012 0.00%
24-06-24 0.012 0.00%
24-06-21 0.012 0.00%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 03:20 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB32GY
ISINDE000MB32GY8
Date issued 2023-02-01
Strike 56.5 $
Maturity 2025-01-17 (205 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.24
Lowest since issue 0.006
Delta0.06x
Omega 6.283
Premium107.09x
Gearing96.85x
Moneyness 0.4853
Difference Strike 29.08 $
Difference Strike %+51.47%
Spread 0.027
Spread %67.50%
Theoretical value 0.0265
Implied Volatility 56.36 %
Total Loss Probability 97.29 %
Intrinsic value 0.000000
Present value 0.0265
Break even 56.78 €
Theta-0x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.42 USD
Average target price
31.92 USD
Spread / Average Target
+16.39%
Consensus